Skip to content

Wednesday, March 29, 2023

Latest:

SQI Diagnostics Submits RALI-Dx(TM) IL-6 Severity Triage Test for COVID-19 Patients to FDA for Emergency Use Authorization
Fusion Pharmaceuticals Appoints Donald Bergstrom, M.D., Ph.D., to Board of Directors
Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan
PsyBio Therapeutics Initiates Process Development of Proprietary Biosynthetic Norbaeocystin
MindMed Announces Inclusion in FTSE Russell Indexes

Biotech Stock Market News

Know First, Act First

Cannabis & Cancer
General
Coronavirus
Financing & Fiscal
Shareholders

NVAX

This is Why Novavax Has Exploded Higher in Just Weeks

June 29, 2020May 24, 2021 Desiree Justice coronavirus, COVID-19, Novavax Inc., NVAX, U.S. Department of Defense, US FDA

Novavax Inc. has been incredibly explosive since May 2020. Since then, the stock has gapped from a low of $19

Cannabis

BIOTCHNO Cannabis & Cancer

Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Renal Cell Carcinoma in Japan

March 31, 2021July 19, 2021 Raza

TOKYO, Mar 31, 2021 – (JCN Newswire) – Eisai Co., Ltd. and MSD K.K. a subsidiary of Merck & Co.,

BIOTCHNO Cannabis & Cancer

The Valens Company Expands Cannabis 2.0 & 3.0

February 25, 2021April 20, 2021 Bachittar

BIOTCHNO Cannabis & Cancer

PAOG Announces CBD Nutraceuticals Expansion Plan Multimedia Presentation

February 16, 2021April 30, 2021 Bachittar

BIOTCHNO Cannabis & Cancer

ESSA Pharma Presents Favorable Initial Phase 1 Clinical Pharmacology Data of EPI-7386 for Advanced Forms of Prostate Cancer at the 2021 ASCO Genitourinary Cancers Symposium

February 11, 2021April 30, 2021 Bachittar

Disclaimer
Privacy Policy

TD Media LLC dba Life Water Media
5826 New Territory Blvd. Unit #2144 Sugar Land, TX 77479